Aortic Stent Grafts Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Summary
GlobalData's Medical Devices sector report, “Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Aortic Stent Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Aortic Stent grafts are used to reinforce a weaken aorta to prevent ruptures.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Aortic Stent Grafts under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Aortic Stent Grafts and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Aortic Stent Grafts under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Aortic Stent Grafts Overview
4 Products under Development
4.1 Aortic Stent Grafts - Pipeline Products by Stage of Development
4.2 Aortic Stent Grafts - Pipeline Products by Segment
4.3 Aortic Stent Grafts - Pipeline Products by Territory
4.4 Aortic Stent Grafts - Pipeline Products by Regulatory Path
4.5 Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
4.6 Aortic Stent Grafts - Ongoing Clinical Trials
5 Aortic Stent Grafts - Pipeline Products under Development by Companies
5.1 Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
5.2 Aortic Stent Grafts – Companies Pipeline Products by Stage of Development
6 Aortic Stent Grafts Companies and Product Overview
6.42.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview
6.43 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
6.43.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
7 Aortic Stent Grafts- Recent Developments
7.1 Nov 10, 2023: Microport Appointment of Director
7.2 Nov 09, 2023: Artivion Announces Completion of Enrollment in PERSEVERE Trial
7.3 Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
7.4 Oct 18, 2023: Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
7.5 Oct 05, 2023: Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting
7.6 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
7.7 Sep 29, 2023: Barry Slowey Named Vice President and Chief Sustainability Officer
7.8 Sep 21, 2023: Microport Endovastec Completes the First Clinical Implantation of Minos Stent Graft System in Azerbaijan
7.1 Sep 15, 2023: Amber Beauchamp Named Vice President of Global Human Resources
7.11 Sep 08, 2023: MicroPort Endovastec's Three Products in the Aortic Intervention Field Have Been Approved in Thailand
7.12 Sep 01, 2023: Japan Lifeline Announces Changes in Organizations and Personnel
7.13 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
7.14 Aug 24, 2023: Endologix Announces that Lucas Buchanan Joins Board of Directors
7.15 Aug 17, 2023: Mayo Clinic Reports Strong Finances for 2023 So Far with Q2 Revenue of $4.47 billion
7.16 Aug 11, 2023: Kristin Peck, CEO of Zoetis, to join Mayo Clinic Board of Trustees
7.17 Aug 11, 2023: W. L. Gore & Associates to Present New Mosa Paper At Gvsets Conference
7.18 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
7.19 Aug 04, 2023: Merit Medical concludes patient enrolment in WAVE trial
7.2 Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility
7.21 Jul 19, 2023: Boston Scientific Lays off 52 Amid California Facility Closure
7.22 Jul 11, 2023: Microport Scientific Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023
7.23 Jul 04, 2023: Terumo Aortic Announces PMDA Approval for Thoraflex Hybrid in Japan
7.24 Jun 23, 2023: FDA approves clinical study of Zenith Fenestrated+ Endovascular Graft for treatment of aortic aneurysms
7.25 Jun 19, 2023: Endospan Announces First Experience with the Personalized NEXUS DUO Aortic Arch Stent Graft System
7.26 Jun 13, 2023: Terumo Aortic Announces Launch of the Global Thoraflex Hybrid EXTEND Study
7.27 Jun 12, 2023: Abbott Names Philip Boudreau CFO effective Sept. 1
7.28 May 31, 2023: Endovastec receives approval for the Minos Abdominal aortic Stent-Graft and Delivery System in Singapore
7.29 May 30, 2023: ‘Korea Needs to Localize Rare Medical Devices Amid Global Supply Shortage’
7.3 May 23, 2023: Endologix announces 150th Patient Enrolled in JAGUAR Randomized Controlled Trial
7.31 May 15, 2023: Terumo announces consolidated financial results for the fiscal year ended March 31, 2023
7.32 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
7.33 May 02, 2023: LeMaitre Q1 2023 financial results
7.34 Apr 27, 2023: Five-Year results of the LEOPARD Trial published in the Journal of Vascular Surgery (JVS)
7.35 Apr 26, 2023: 10-year data from the medtronic ENGAGE OUS registry is the first and only prospective, industry sponsored global EVAR registry to demonstrate a decade of durable outcomes in real-world setting
7.36 Apr 26, 2023: Merit Medical reports results for first quarter March 31, 2023
7.37 Apr 26, 2023: MicroPort announces annual results for 2022
7.38 Apr 24, 2023: Endovastec has completed the first clinical cases of two products in Colombia
7.39 Apr 24, 2023: Endovastec received approval for Hercules -LP Thoracic Stent Graft in Singapore
7.4 Apr 12, 2023: Medtronic has a layoff in California
7.41 Apr 06, 2023: Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023
7.42 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
7.43 Feb 23, 2023: LeMaitre Q4 2022 Financial Results
7.44 Feb 15, 2023: First Implantation of Endovastec's Castor Branched Aortic Stent-Graft System Completed in Netherlands
7.45 Feb 09, 2023: Terumo Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023
7.46 Feb 09, 2023: Terumo Corp Announces Consolidated Financial Results for the Third Quarter Ended December 31, 2022
7.47 Feb 03, 2023: Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023
7.48 Feb 01, 2023: Japan Lifeline Announces Consolidated Financial Results for the Nine months Ended December 31, 2022
7.49 Jan 11, 2023: Medtronic announces first enrollment in head-to-head global randomized trial evaluating durability of endovascular aneurysm repair
7.5 Jan 04, 2023: Endovastec Minos abdominal aortic stent-graft and delivery system receives approval for marketing in South Korea
7.51 Dec 30, 2022: 6 Endovastec products approved for marketing in Belarus
7.52 Dec 07, 2022: Endologix receives FDA approval of PMA supplement for AFX2 system
7.53 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Aortic Stent Grafts - Pipeline Products by Stage of Development
Table 2: Aortic Stent Grafts - Pipeline Products by Segment
Table 3: Aortic Stent Grafts - Pipeline Products by Territory
Table 22: Ascyrus Medical Dissection Stent - Product Status
Table 23: Ascyrus Medical Dissection Stent - Product Description
Table 24: Ascyrus Medical LLC - Ongoing Clinical Trials Overview
Table 25: Ascyrus Medical Dissection Stent - A Prospective, Single Arm, Multi-center Clinical Investigation to Evaluate the Safety and Effectiveness of AMDS in the Treatment of Acute DeBakey Type I Dissection: PERSEVERE
Table 26: Ascyrus Medical Dissection Stent - Dissected Aorta Repair Through Stent Implantation (DARTS): A Feasibility Study
Table 27: Ascyrus Medical Dissection Stent - Dissected Aorta Repair Through Stent Implantation (DARTS): A Feasibility, Safety and Performance Trial
Table 28: Ascyrus Medical Dissection Stent - Dissected Aorta Repair through Stent Implantation (DARTS): A Post-market Registry
Table 29: Ascyrus Medical Dissection Stent - Randomized Trial on Acutely Dissected Aorta Repair with Hemiarch Replacement With or Without Stent Implantation (RADAR Trial)
Table 30: Beijing Tianzhu Ruichang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Three-Branch Thoracic Aorta Stent Graft System - Product Status
Table 44: Cook Medical Inc - Ongoing Clinical Trials Overview
Table 45: Zenith P-Branch - Zenith p-Branch Pivotal Study
Table 46: Zenith Fenestrated+ Endovascular Graft - Safety and Effectiveness of Surgeon-Modified Fenestrated and Branched Endografts in Treating Subjects With Complex Aortic Aneurysms
Table 75: Nellix EVAS System - Multicenter, Observational, Registry to Assess Outcomes of Patients Treated With the CE Marked Nellix System for Endovascular Abdominal Aortic Aneurysm Repair
Table 76: Nellix EVAS System - Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System IDE Study: EVAS 2 Confirmatory IDE Study
Table 77: Nellix CHEVAS - Prospective, Multicenter, Non-randomized Study with Consecutive, Eligible Subject Enrollment at Each Site, for the Evaluation of the ChEVAS System for Endovascular Repair of Paravisceral, Juxtarenal, and Pararenal Abdominal Aortic Aneurysms
Table 85: Nexus Aortic Arch Stent Graft System - A Multi-arm, Multi-center, Non-randomized, Prospective, Clinical Study to Evaluate the Safety and Effectiveness of the NEXUS Aortic Arch Stent Graft System in Treating Thoracic Aortic Lesions Involving the Aortic Arch
Table 86: Nexus Aortic Arch Stent Graft System - A Non-Randomized, Prospective, Open-Label, Multi-Center, Observational Clinical Study to Further Evaluate Safety and Performance of the NEXUS Aortic Arch Stent Graft System
Table 87: Nexus Aortic Arch Stent Graft System - ENDOBARC-S Study: Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain
Table 88: Nexus Aortic Arch Stent Graft System - NEXUS Aortic Arch Stent Graft System Data Collection Study for Compassionate-Use Procedures
Table 89: Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 90: TAS System - Product Status
Table 91: TAS System - Product Description
Table 92: Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table 93: In Situ Weldable Hybrid Stent - Product Status
Table 94: In Situ Weldable Hybrid Stent - Product Description
Table 101: WeFlow-Arch Modeler Embedded Branch Stent Graft System - Guo's Aortic Arch Reconstruction: The First in Man Study of WeFlow-Arch Modular Embedded Branch Stent Graft System
Table 102: WeFlow-Arch Modeler Embedded Branch Stent Graft System - Guo's Aortic Arch Reconstruction: The Prospective, Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System (GIANT Study)
Table 103: WeFlow-Tbranch Stent Graft System - Guo's Endovascular Aortic Arch Replacement of Aortic Dissection by WeFlow-Tribranch Endoprothesis: A Multicenter Pilot Study (Graft Study)
Table 104: WeFlow-Tbranch Stent Graft System - Guo's Subclavian Artery Reconstruction: The Prospective, Multiple Center Study of WeFlow-Tbranch Stent Graft System (GUEST Study)
Table 105: WeFlow-Tbranch Stent Graft System - New Technology Clinical Study on the Safety and Efficacy of WeFlow-Tribranch Aortic Arch Stent Graft System in the Treatment of Patients with Aortic Arch Dissection
Table 124: E-liac Stent Graft System - Prospective Multicenter Registry to Examine the Real-world Performance of the E-liac Stent Graft System for Treatment of Uni- or Bilateral Aorto-iliac or Iliac Aneurysms
Table 125: E-liac Stent Graft System - Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm with the Branched E-liac Stent Graft
Table 126: E-nya Thoracic Stent Graft - CONFORM-TAA - A Post-market Clinical Follow-up Study in Patients with a Descending Thoracic Aortic Aneurysm or Penetrating Aortic Ulcer (PAU) Treated with the E-nya Thoracic Stent Graft System
Table 127: E-nya Thoracic Stent Graft - CONFORM-TAD- A Post-market Clinical Follow-up Study in Patients with Complicated Acute, Subacute or Chronic Type B Aortic Dissection with Double Lumen Treated with the E-nya Thoracic Stent Graft System
Table 128: E-nside TAAA Stent Graft - INNER-B - A Post-market Clinical Follow-up Study in Patients with Thoracoabdominal Aortic Aneurysms Treated with E-nside TAAA Multibranch Stent Graft System
Table 129: E-nside TAAA Stent Graft - INNER-B-APAC - Asian Pacific Post-market Clinical Follow-up Study in Patients with Thoracoabdominal Aortic Aneurysms Treated with E-nside TAAA Multibranch Stent Graft System
Table 130: E-Vita Open Neo - A Post-market Clinical Follow-up Study in Patients with Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated with E-vita OPEN NEO: NEOS
Table 131: E-Vita Open Neo - NEO - E-vita Open Neo Treatment of Aortic Arch Aneurysms and Dissections
Table 132: E-Vita Open Neo - NEOS-APAC - Asian Pacific Post-market Clinical Follow-up Study in Patients with Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated with E-vita OPEN NEO
Table 140: G-Branch Thoracic-Abdominal Aorta Stent Graft System - Guo's Renovisceral Artery Reconstruction-1: A Prospective, Multicenter, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of a Multi-branched Stent Graft System for Thoracoabdominal Aortic Aneurysm (GUARANTEE Study) 7
Table 141: Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 142: FEVAR - Product Status
Table 143: FEVAR - Product Description
Table 144: TEVAR - Product Status
Table 145: TEVAR - Product Description
Table 146: Lombard Medical Technologies Inc. - Ongoing Clinical Trials Overview
Table 164: Valiant Mona LSA System - Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Descending Thoracic Aortic Aneurysms and Chronic Dissections 7
Table 165: Valiant TAAA Stent Graft System - Endograft Repair of Thoracoabdominal Aortic Aneurysms (TAAA) 8
Table 166: Valiant TAAA Stent Graft System - Visceral Manifold and Unitary Device Study for the Repair of Thoracoabdominal Aortic Aneurysms 8
Table 167: Valiant TAAA Stent Graft System - Visceral Manifold Study for the Repair of Thoracoabdominal Aortic Aneurysms 8
Table 168: Unitary Manifold Stent Graft System - Visceral Manifold and Unitary Device Study for the Repair of Thoracoabdominal Aortic Aneurysms
Table 169: Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 174: Merit Medical Systems Inc - Ongoing Clinical Trials Overview
Table 175: WRAPSODY Endovascular Stent Graft - Arteriovenous Fistula - Prospective, Multicenter, Observational Study to Evaluate the Merit WRAPSODY Endoprosthesis for Treatment of Stenosis or Occlusion within the Dialysis Outflow Circuit of an Arteriovenous (AVF) Fistula or AV Graft (AVG) (The WRAP Registry)
Table 183: PerMed Branch Stent Graft - A Prospective, Multicenter, Open, Randomized Controlled, Non Inferiority Clinical Trial to Evaluate the Safety and Efficacy the Branch-based Intraoperative Stent System in the Treatment of Stanford A Aortic Dissection 6
Table 190: Shanghai MicroPort Endovascular MedTech Group Co Ltd - Ongoing Clinical Trials Overview 9
Table 191: Cratos Branched Aortic Stent Graft System - A Prospective, Multicenter, Single-group Clinical Trial to Evaluate the Efficacy and Safety of the Cratos Branch Aortic Covered Stent System in the Treatment of Stanford Type B Aortic Dissection 9
Table 192: Cratos Branched Aortic Stent Graft System - Evaluation of Cratos Branch Stent Graft System in Treatment of Descending Aorta Lesions 9
Table 193: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 0